Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020
- Friday, May 8, 2020, 7:11
- PR Newswire
- Add a comment
HOUSTON, May 8, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its intention to adjourn its 2020 Annual…
About the Author
admin has written 21810 stories on this site.